← Back to Search

Goal Management Training (GMT) for Post-Traumatic Stress Disorder

N/A

Waitlist Available

Led By Ruth A. Lanius, MD, PhD

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if Goal Management Training (GMT) can help adults with PTSD, including COVID-19 frontline workers, improve their thinking skills. GMT teaches strategies for better goal and task management. Participants will either start GMT right away or wait for a few months before beginning the program. GMT is designed to improve attention and thinking skills.

Eligible Conditions

Post Traumatic Stress Disorder
Cognitive Impairment
PTSD

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment

Change in Clinician Administered PTSD Scale (CAPS) score from post-treatment to 3-month follow-up assessment

Change in Difficulties in Emotion Regulation Scale (DERS) score from baseline to post-treatment assessment

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Goal Management Training (GMT)Experimental Treatment1 Intervention

Participants in this arm will attend 9 weekly, 2-hour group GMT appointments.

Group II: Wait ListActive Control1 Intervention

Participants in this arm will receive no treatment for approximately 21 weeks (at which point, they will be offered the same, standard GMT treatment).

Do I qualify?Apply below to find out